- Home
- NKTR vs ALTS Comparison
NKTR vs ALTS Comparison
Compare NKTR & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- ALTS
- Stock Information
- Founded
- NKTR 1990
- ALTS 1976
- Country
- NKTR United States
- ALTS United States
- Employees
- NKTR N/A
- ALTS N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- ALTS
- Sector
- NKTR Health Care
- ALTS
- Exchange
- NKTR Nasdaq
- ALTS NYSE
- Market Cap
- NKTR 108.3M
- ALTS 125.5M
- IPO Year
- NKTR 1994
- ALTS N/A
- Fundamental
- Price
- NKTR $24.73
- ALTS $7.45
- Analyst Decision
- NKTR Strong Buy
- ALTS
- Analyst Count
- NKTR 6
- ALTS 0
- Target Price
- NKTR $81.67
- ALTS N/A
- AVG Volume (30 Days)
- NKTR 4.9M
- ALTS 304.5K
- Earning Date
- NKTR 08-07-2025
- ALTS 08-18-2025
- Dividend Yield
- NKTR N/A
- ALTS N/A
- EPS Growth
- NKTR N/A
- ALTS N/A
- EPS
- NKTR N/A
- ALTS N/A
- Revenue
- NKTR $87,248,000.00
- ALTS $18,046,000.00
- Revenue This Year
- NKTR N/A
- ALTS $185.91
- Revenue Next Year
- NKTR N/A
- ALTS $64.93
- P/E Ratio
- NKTR N/A
- ALTS N/A
- Revenue Growth
- NKTR N/A
- ALTS N/A
- 52 Week Low
- NKTR $6.48
- ALTS $1.29
- 52 Week High
- NKTR $37.38
- ALTS $10.95
- Technical
- Relative Strength Index (RSI)
- NKTR 67.01
- ALTS 49.44
- Support Level
- NKTR $21.87
- ALTS $6.60
- Resistance Level
- NKTR $26.89
- ALTS $8.12
- Average True Range (ATR)
- NKTR 2.11
- ALTS 0.79
- MACD
- NKTR -0.20
- ALTS -0.03
- Stochastic Oscillator
- NKTR 76.31
- ALTS 68.18
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.